Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica

Open access
Herrero, Rolando, Hildesheim, Allan, Rodríguez, Ana C., Wacholder, Sholom, Bratti, Concepción, Solomon, Diane, González, Paula, Porras, Carolina, Jiménez, Silvia, Guillen, Diego, Morales, Jorge, Alfaro, Mario, Cyr, Jean, Morrisey, Kerrygrace, Estrada, Yenory, Cortés, Bernal, Morera, Lidia Ana, Freer, Enrique, Schussler, John, Schiller, John, Lowy, Douglas, Schiffman, Mark·2008·Vaccine

Abstract

We report the rationale, design, methods and details of participation of a community-based, double blind, randomized clinical trial of an HPV 16 and 18 vaccine conducted in two provinces of Costa Rica to investigate the efficacy and population impact of the vaccine in the prevention of cervical cancer precursors. More than 24,000 women between 18 and 25 years of age were invited to participate and pre-screened for eligibility, with recruitment of 7,466 women (30% of those prescreened, 59% of those eligible) who were randomized to receive 3 doses of the HPV vaccine or hepatitis A vaccine as control. A complex protocol of data and specimen collection was applied, including an interview, pelvic exam for sexually active women, blood for serology and cell-mediated immunity, cervical secretions for local immunity and cells for HPV, Chlamydia trachomatis and Gonorrhea testing. Eighty percent of the women received 3 doses, 12.4% two doses and 7.4% one dose. At visits, compliance with data and specimen collection was close to 100%. Baseline characteristics and age-specific prevalence of HPV and cervical neoplasia are reported. Overall prevalence of HPV was high (50%), with 8.3% of women having HPV 16 and 3.2% HPV 18. LSIL was detected in 12.7% of women at baseline and HSIL in 1.9%. Prevalence of Chlamydia was 14.2%. There was very good agreement in HPV detection between clinician-collected and self-collected specimens (89.4% agreement for all types, kappa 0.59). Follow up will continue with yearly or more frequent examinations for at least 4 years for each participant.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.vaccine.2008.07.002

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 169

Metadata

Authors
Herrero, R., Hildesheim, A., Rodríguez, A. C., Wacholder, S., Bratti, C., Solomon, D., González, P., Porras, C., Jiménez, S., Guillen, D., Morales, J., Alfaro, M., Cyr, J., Morrisey, K., Estrada, Y., Cortés, B., Morera, L. A., Freer, E., Schussler, J., Schiller, J., Lowy, D., & Schiffman, M.
Venue
Vaccine
Publisher
Elsevier BV
Published
2008-09
Volume
26
Issue
37
Pages
4795-4808
ISSN
0264-410X (ISSN-L)
OpenAlex
W2062597040
Cited by
169
References
2
FWCI
6.13
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. https://app.cochat.ai/papers/10.1016/j.vaccine.2008.07.002
The paper
Herrero, R., Hildesheim, A., Rodríguez, A. C., Wacholder, S., Bratti, C., Solomon, D., González, P., Porras, C., Jiménez, S., Guillen, D., Morales, J., Alfaro, M., Cyr, J., Morrisey, K., Estrada, Y., Cortés, B., Morera, L. A., Freer, E., Schussler, J., . . . Schiffman, M. (2008). Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. Vaccine. https://doi.org/10.1016/j.vaccine.2008.07.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.